Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

China Resources Double‑Crane Subsidiary Secures NMPA Approval for Vortioxetine Hydrobromide API – Vertically Integrating Its Antidepressant Franchise
CompanyDrug

China Resources Double‑Crane Subsidiary Secures NMPA Approval for Vortioxetine Hydrobromide API – Vertically Integrating Its Antidepressant Franchise

China Resources Double‑Crane Pharmaceutical Co., Ltd. (SHA: 600062) announced that its controlled subsidiary, China Resources Double‑Crane Xiangzhong Pharmaceutical (Hunan) Co., Ltd. ("Double‑Crane Xiangzhong"), has received the "Chemical API Marketing Application…

AstraZeneca and Daiichi Sankyo's Enhertu Wins NMPA Approval in HER2‑Positive Early Breast Cancer – New Adjuvant Indication and Full Approval of Neoadjuvant Label in China

AstraZeneca and Daiichi Sankyo’s Enhertu Wins NMPA Approval in HER2‑Positive Early Breast Cancer – New Adjuvant Indication and Full Approval of Neoadjuvant Label in China

Hansoh Pharmaceutical Resubmits Aumuletinib MAA to the EMA – EGFR‑TKI Application Validated for Two Advanced NSCLC Indications After EU Market Withdrawal

Hansoh Pharmaceutical Resubmits Aumuletinib MAA to the EMA – EGFR‑TKI Application Validated for Two Advanced NSCLC Indications After EU Market Withdrawal

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Nanjing Immunophage Biotech’s IPG11406 Approved for SLE Clinical Trial in China

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval for SHR-A1811 and Pyrotinib Combo Study

CompanyDrug

Mabwell Bioscience Receives NMPA Approval to Launch 9MW2921 Clinical Study

CompanyDrug

Betta Pharmaceuticals’ MCLA-129 Combo Therapy for NSCLC Gets NMPA Clinical Approval

CompanyDrug

Pfizer Launches Phase III Trial for Quadrivalent Influenza modRNA Vaccine in Argentina

CompanyDrug

Zai Lab Initiates Phase III Trial for Bemarituzumab in First-Line Gastric Cancer Treatment

CompanyDrug

GRIT Biotechnology’s GT201 TIL Therapy Approved for Clinical Studies by China’s CDE

CompanyDrug

Jiangsu Hengrui Pharmaceuticals’ Irinotecan and Bupivacaine Liposome Injections Get Clinical Trial Green Light in China

Show More